Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring

Inclusion Criteria: * Pregnant individuals age 18 and older * Diagnosed with gestational diabetes by the Diabetes Canada guidelines (including both the preferred or alternate testing approaches) or have an HbA1c of 6.0-6.4% during pregnancy * Have any of the following: have an elevated fasting glucose (≥ 5.3 mmol/L) on the diagnostic 75g OGTT in pregnancy; required insulin or metformin for treatment during pregnancy; body mass index (BMI) ≥ 25kg/m\^2, yes/no (\<27 weeks gestation BMI of ≥25 kg/m\^2 or ≥27 weeks gestation predicted BMI of ≥ 25 kg/m\^2 using (current weight in kg - 10kg)/height in meters\^2) * Planned in-hospital delivery * Able to provide informed consent * Willingness to use the study device and complete assessments postpartum * Have access to email in order to complete participant questionnaire through REDCap Exclusion Criteria: * A clinical diagnosis of non-gestational diabetes (i.e., pre-existing type 1 or 2 diabetes) prior to or during pregnancy * Planned x-ray, MRI or CT within 3 weeks postpartum * Has an implantable medical device (ex. pacemaker) * On medications known to affect glucose metabolism (for example glucocorticoids, metformin etc.) while wearing the CGM postpartum * On medications which may interfere with the Freestyle Libre 2 accuracy (for example Vitamin C \>1000mg/day) while wearing the CGM postpartum * Unable to speak and understand French or English * Unable to consent or declined informed consent